NewsRamp Health & Wellness Podcast

NRx Pharmaceuticals is progressing with regulatory approval for NRX-100, focusing on treatments for suicidal depression and PTSD. Nutriband Inc. sets key dates for a stock dividend tied to FDA approval of their AVERSA Fentanyl product. SeaStar Medical and AREVA collaborate to advance treatments for severe burns with a grant from the US Department of Defense. Additionally, a study highlights early medical attention patterns in individuals later diagnosed with multiple sclerosis, emphasizing the importance of early detection. Finally, CNS Pharmaceuticals undergoes a reverse stock split, while Soligenix Inc. reports positive results in a real-world trial for its HyBryte(TM) treatment for cutaneous T-cell lymphoma patients.

ABVC BioPharma receives a milestone payment for ophthalmic drug development, aiming for a $1.0 billion value partnership. KidzCare Pediatrics integrates Oceanside Pediatrics for enhanced pediatric services in North Carolina. The VENTOUX study highlights potential heart health risks in male endurance athletes over 50, emphasizing the importance of monitoring symptoms.

Chronic Venous Insufficiency (CVI) is a common condition linked to cardiovascular risk factors, with notable cases like President Donald Trump's recent diagnosis. Treatment options include compression therapy and medications. Fifty 1 Labs, Inc. is collaborating with BioSpark AI Technologies Inc. to enhance drug repurposing using AI. Additionally, the rise of non-smokers diagnosed with lung cancer is prompting research and innovative treatments by companies like Calidi Biotherapeutics Inc.

Explore the latest advancements in healthcare technology, personalized concierge medical care, therapy services, cardiac rhythm management, and a scholarship opportunity for aspiring medical students, all aimed at improving patient care, access, and education in the healthcare industry.

This podcast episode covers updates from various biomedical companies, including Genascence Corporation receiving FDA designation for a gene therapy targeting knee osteoarthritis, NRx Pharmaceuticals expanding its mental health clinics and advancing NMDA-based therapies, Lantern Pharma utilizing AI for precision oncology drug development, and more. Exciting developments in areas such as regenerative medicine, mental health therapeutics, oncology drug discovery, and viral infection treatments are highlighted, showcasing the diverse range of advancements in the biomedical field.

Baltimore's federal delegation, led by Mayor Brandon Scott, highlighted improvements in crime rates and overdose deaths while emphasizing the threat of federal actions on progress. Soligenix Inc. and Izotropic Corporation are advancing in rare disease treatments and breast cancer imaging, respectively. Lantern Pharma introduces an AI module for oncology drug development, while Kairos Pharma reports positive results in a prostate cancer drug study. Intelligent Bio Solutions expands its non-invasive drug testing portfolio, and HealthLynked Corp. engages Meridian Group to drive strategic partnerships and Nasdaq uplisting goals.

Ethema Health Corporation provides a shareholder update on public filings, revenue projections, and operational achievements. Diopter Technologies introduces a groundbreaking dissolving amniotic membrane biopolymer contact lens for ocular surface diseases, aiming to revolutionize ocular surface rehabilitation. Curebound, led by COO Karen Hooper, focuses on accelerating cancer cures through innovative research and fundraising efforts, emphasizing community support in the face of NIH funding cuts.

Branded Legacy (OTC: BLEG) undergoes a leadership transition and plans a merger to enter addiction therapeutics. H+Trace revolutionizes healthcare logistics with real-time tracking and AI technology. Sino Biological US, Inc. introduces ProPure™, a new line of endotoxin-free recombinant proteins. The American Heart Association launches an initiative to improve surgical protocols for hemorrhagic strokes, supported by Stryker.

NanoViricides is conducting a Phase II trial for its MPox drug NV-387, aiming to combat Clade 1b MPox in Africa. Asepha, a startup specializing in AI-powered pharmacy automation, has secured funding to streamline pharmacy operations using AI agents. GeoVax Labs will present updates on its vaccine programs at the Emerging Growth Conference, including GEO-MVA and GEO-CM04S1 for COVID-19.

Forest Pest Control, based in Lake Mary, is committed to protecting homes from termite invasions. Their skilled team offers thorough inspection and treatment options, focusing on customer satisfaction, transparency, and education to ensure clients feel supported and informed while preserving the safety and value of their properties.